Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance

Clinical trial NCT06995833 · RECRUITING

Trial details

NCT number: NCT06995833
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Endometrial Cancer

Start date: 2025-09-19
Primary completion: 2029-06-29
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.